These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9205075

  • 1. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC.
    Cancer Res; 1997 Jul 01; 57(13):2668-75. PubMed ID: 9205075
    [Abstract] [Full Text] [Related]

  • 2. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN.
    Oncogene; 1997 Jul 10; 15(2):143-57. PubMed ID: 9244350
    [Abstract] [Full Text] [Related]

  • 3. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 4. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG, Moses HL.
    J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150
    [Abstract] [Full Text] [Related]

  • 5. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
    Birchenall-Roberts MC, Kim SJ, Bertolette DC, Turley JM, Fu T, Bang OS, Kasper JJ, Yoo YD, Ruscetti FW.
    Oncogene; 1996 Oct 03; 13(7):1499-509. PubMed ID: 8875988
    [Abstract] [Full Text] [Related]

  • 6. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F, Lovec H, Möröy T, Lipp M.
    Oncogene; 1994 Jul 03; 9(7):2029-36. PubMed ID: 8208548
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D, Schulze A, Boye B, Jansen-Dürr P.
    Cell Growth Differ; 1997 Jun 03; 8(6):699-710. PubMed ID: 9186003
    [Abstract] [Full Text] [Related]

  • 8. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K, Vlach J, Hennecke S, Amati B.
    EMBO J; 1997 Sep 01; 16(17):5322-33. PubMed ID: 9311992
    [Abstract] [Full Text] [Related]

  • 9. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH.
    Oncogene; 2008 Jan 10; 27(3):366-77. PubMed ID: 17637753
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
    Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM.
    Exp Cell Res; 1997 Aug 01; 234(2):293-9. PubMed ID: 9260897
    [Abstract] [Full Text] [Related]

  • 11. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 12. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 13. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH.
    Oncogene; 2004 Oct 28; 23(50):8238-46. PubMed ID: 15378019
    [Abstract] [Full Text] [Related]

  • 14. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
    Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.
    Li WW, Fan J, Hochhauser D, Bertino JR.
    Cancer Res; 1997 Jun 01; 57(11):2193-9. PubMed ID: 9187120
    [Abstract] [Full Text] [Related]

  • 16. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A.
    Cell Death Differ; 1998 May 01; 5(5):381-9. PubMed ID: 10200487
    [Abstract] [Full Text] [Related]

  • 17. Functional roles of E2F in cell cycle regulation.
    Fan J, Bertino JR.
    Oncogene; 1997 Mar 13; 14(10):1191-200. PubMed ID: 9121768
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H, Iavarone A, Reeves SA.
    Oncogene; 1998 Mar 26; 16(12):1513-23. PubMed ID: 9569018
    [Abstract] [Full Text] [Related]

  • 19. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
    Sala A, Nicolaides NC, Engelhard A, Bellon T, Lawe DC, Arnold A, Graña X, Giordano A, Calabretta B.
    Cancer Res; 1994 Mar 15; 54(6):1402-6. PubMed ID: 8137237
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M, Fan S, Ström AC, Helin K, Akusjärvi G.
    Virology; 1999 Apr 10; 256(2):313-21. PubMed ID: 10191196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.